These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8427294)
1. Southwestern internal medicine conference: growth hormone--aging and osteoporosis. Rubin CD Am J Med Sci; 1993 Feb; 305(2):120-9. PubMed ID: 8427294 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy in the elderly: implications for the aging brain. Hoffman AR; Lieberman SA; Ceda GP Psychoneuroendocrinology; 1992 Aug; 17(4):327-33. PubMed ID: 1438653 [TBL] [Abstract][Full Text] [Related]
3. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children? Lanes R; Jakubowicz S J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186 [TBL] [Abstract][Full Text] [Related]
4. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. Kassem M; Brixen K; Blum WF; Mosekilde L; Eriksen EF J Bone Miner Res; 1994 Sep; 9(9):1365-70. PubMed ID: 7817819 [TBL] [Abstract][Full Text] [Related]
5. [New physiological and pharmacological aspects of the growth hormone (II). Therapeutic applications in adults]. Díez JJ; Gómez-Pan A Rev Clin Esp; 1993 Apr; 192(7):334-42. PubMed ID: 8497741 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging. Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854 [TBL] [Abstract][Full Text] [Related]
7. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age. Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895 [TBL] [Abstract][Full Text] [Related]
8. Effects of the selective estrogen receptor modulator, raloxifene, on the somatotropic axis and insulin-glucose homeostasis. Oleksik AM; Duong T; Pliester N; Asma G; Popp-Snijders C; Lips P J Clin Endocrinol Metab; 2001 Jun; 86(6):2763-8. PubMed ID: 11397884 [TBL] [Abstract][Full Text] [Related]
9. Osteoporosis and the growth hormone-insulin-like growth factor axis. Geusens PP; Boonen S Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis. Brixen K; Kassem M; Eriksen EF; Nielsen HK; Flyvbjerg A; Mosekilde L J Pediatr Endocrinol; 1993; 6(1):65-71. PubMed ID: 8374692 [TBL] [Abstract][Full Text] [Related]
12. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753 [TBL] [Abstract][Full Text] [Related]
13. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049 [TBL] [Abstract][Full Text] [Related]
14. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973 [TBL] [Abstract][Full Text] [Related]
16. Role of IGF-I in muscular atrophy of aging. Borst SE; Lowenthal DT Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034 [TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. Johansson AG; Lindh E; Blum WF; Kollerup G; Sørensen OH; Ljunghall S J Clin Endocrinol Metab; 1996 Jan; 81(1):44-8. PubMed ID: 8550792 [TBL] [Abstract][Full Text] [Related]
18. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841 [TBL] [Abstract][Full Text] [Related]
19. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis. Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Yuen KC; Dunger DB Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]